Dr. Toledo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 Fifth Avenue
Falk Clinic
Pittsburgh, PA 15213Phone+1 412-383-8700
Summary
- Dr. Frederico Toledo is an endocrinologist in Pittsburgh, PA and a Professor of Medicine at the University of Pittsburgh. He received his medical degree from Faculdade de Medicina da Universidade Federal do Rio de Janeiro and has been in practice for 25 years. He specializes in diabetes and lipid metabolism and is experienced in morbid obesity, diabetes mellitus, obesity and obesity-related disorders, biopsies, and insulin resistance. He leads a large clinical research program in diabetes and human metabolism. He has more than 100 publications and over 7000 citations.
Education & Training
UPMC Medical EducationFellowship, Endocrinology, Diabetes, and Metabolism, 2002 - 2004
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1999 - 2002
Faculdade de Medicina da Universidade Federal do Rio de JaneiroClass of 1995
Certifications & Licensure
PA State Medical License 2002 - 2024- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
- Diabetes Care Recognition Health Care Incentives Improvement Institute
Clinical Trials
- Mitochondrial Dysfunction in Type 2 Diabetes Mellitus and Capacity for Fat Oxidation During Exercise Start of enrollment: 2006 Sep 01
- Reducing Risk of Type 2 Diabetes: Hydroxychloroquine Use in Pre-Diabetes Start of enrollment: 2011 Mar 01
- TREAT (Telemedicine for Reach, Education, Access, and Treatment) Start of enrollment: 2011 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Pancreatic Cancer-Induced Metabolic Dysregulation Syndrome: Clinical Profile, Proposed Mechanisms, and Unanswered Questions.LaNisha Patterson, Frederico G S Toledo, Anirban Maitra, Suresh T Chari
Gastroenterology. 2024-12-01 - Intermittent fasting for systemic triglyceride metabolic reprogramming (IFAST): Design and methods of a prospective, randomized, controlled trial.Jacob A Quaytman, Natalie L David, Sharini Venugopal, Tânia Amorim, Britney Beatrice
Contemporary Clinical Trials. 2024-11-01 - Sex differences in the association between skeletal muscle energetics and perceived physical fatigability: the Study of Muscle, Mobility and Aging (SOMMA).Emma L Gay, Paul M Coen, Stephanie Harrison, Reagan E Garcia, Yujia Susanna Qiao
Geroscience. 2024-10-22
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
